Former Nutraceutical International Corp. directors and the private equity firm that acquired the business for $446 million in 2017 have agreed to pay $17.5 million to end a proposed Delaware Chancery Court investor class action alleging that the take-private deal was unfair and tainted by conflicts of interest.